4-(1H-IMIDAZOL-5-YL)-1H-PYRROLO [2,3-B] PYRIDINES FOR USE IN THE TREATMENT OF LEUKAEMIAS, LYMPHOMAS AND SOLID TUMORS

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14310%2F23%3A00133614" target="_blank" >RIV/00216224:14310/23:00133614 - isvavai.cz</a>
Result on the web
<a href="https://worldwide.espacenet.com/patent/search/family/061837684/publication/CN111936496B?q=pn%3DCN111936496B" target="_blank" >https://worldwide.espacenet.com/patent/search/family/061837684/publication/CN111936496B?q=pn%3DCN111936496B</a>
DOI - Digital Object Identifier
—

Result language
čínština
Original language name
4-(1H-IMIDAZOL-5-YL)-1H-PYRROLO [2,3-B] PYRIDINES FOR USE IN THE TREATMENT OF LEUKAEMIAS, LYMPHOMAS AND SOLID TUMORS
Original language description
The present invention relates to novel 4-(1H-imidazol-5-yl)-1H-pyrrolo[2,3-b]pyridine compounds which are useful in the treatment of lymphomas, leukaemias, and solid tumors.
Czech name
—
Czech description
—

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2023
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Patent/design ID
CN111936496
Publisher
CN002 -
Publisher name
Patent Office - State Intellectual Property Office of the Peoples` Republic of China (SIPO)
Place of publication
Beijing
Publication country
CN - CHINA
Date of acceptance
Dec 29, 2023
Owner name
Masarykova univerzita
Method of use
A - Výsledek využívá pouze poskytovatel
Usage type
A - K využití výsledku jiným subjektem je vždy nutné nabytí licence

Similar results(10)